A detailed history of High Point Advisor Group LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, High Point Advisor Group LLC holds 56,767 shares of BMY stock, worth $3.29 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
56,767
Previous 59,523 4.63%
Holding current value
$3.29 Million
Previous $2.47 Million 18.86%
% of portfolio
0.18%
Previous 0.14%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$39.66 - $51.75 $109,302 - $142,623
-2,756 Reduced 4.63%
56,767 $2.94 Million
Q2 2024

Aug 08, 2024

BUY
$40.25 - $52.99 $295,757 - $389,370
7,348 Added 14.08%
59,523 $2.47 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $18,040 - $20,454
-376 Reduced 0.72%
52,175 $2.83 Million
Q4 2023

Mar 26, 2024

SELL
$48.48 - $57.85 $891,692 - $1.06 Million
-18,393 Reduced 25.93%
52,551 $2.7 Million
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $780,810 - $859,944
10,752 Added 17.86%
70,944 $5.41 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $80,530 - $94,330
1,361 Added 2.31%
60,192 $3.56 Million
Q2 2021

Jul 29, 2021

BUY
$61.91 - $67.42 $649,745 - $707,572
10,495 Added 21.71%
58,831 $3.93 Million
Q1 2021

Apr 12, 2021

BUY
$59.34 - $66.74 $91,383 - $102,779
1,540 Added 3.29%
48,336 $3.03 Million
Q4 2020

Feb 10, 2021

BUY
$57.74 - $65.43 $123,274 - $139,693
2,135 Added 4.78%
46,796 $2.8 Million
Q3 2020

Nov 06, 2020

BUY
$57.43 - $63.64 $638,908 - $707,995
11,125 Added 33.17%
44,661 $2.85 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $37,551 - $43,901
685 Added 2.09%
33,536 $1.99 Million
Q1 2020

May 01, 2020

BUY
$46.4 - $67.43 $1.43 Million - $2.08 Million
30,806 Added 1506.41%
32,851 $2.05 Million
Q1 2020

Apr 27, 2020

SELL
$46.4 - $67.43 $1.38 Million - $2.01 Million
-29,776 Reduced 93.57%
2,045 $32.9 Million
Q4 2019

Feb 13, 2020

BUY
$49.21 - $64.19 $476,549 - $621,615
9,684 Added 43.75%
31,821 $2.14 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $77,926 - $92,393
1,822 Added 8.97%
22,137 $1.28 Million
Q2 2019

Aug 15, 2019

BUY
$44.62 - $49.34 $7,496 - $8,289
168 Added 0.83%
20,315 $868,000
Q1 2019

May 08, 2019

BUY
$45.12 - $53.8 $29,688 - $35,400
658 Added 3.38%
20,147 $951,000
Q4 2018

Feb 20, 2019

BUY
$48.76 - $63.23 $75,139 - $97,437
1,541 Added 8.59%
19,489 $1 Million
Q3 2018

Oct 24, 2018

BUY
$55.19 - $62.25 $5,243 - $5,913
95 Added 0.53%
17,948 $913,000
Q2 2018

Aug 20, 2018

SELL
$50.53 - $62.98 $148,962 - $185,665
-2,948 Reduced 14.17%
17,853 $1.09 Million
Q1 2018

Jun 11, 2018

BUY
$59.92 - $68.98 $86,164 - $99,193
1,438 Added 7.43%
20,801 $1.11 Million
Q4 2017

Feb 15, 2018

BUY
$59.94 - $65.35 $20,559 - $22,415
343 Added 1.8%
19,363 $1.24 Million
Q3 2017

Nov 06, 2017

BUY
$55.23 - $63.74 $1.05 Million - $1.21 Million
19,020
19,020 $1.18 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.